Sharon J. Pitteri

Chemistry · Physical Sciences

48h-index8.9kcitations273works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Proteomics Techniques and Applications(60), Glycosylation and Glycoproteins Research(56), Cancer, Lipids, and Metabolism(38), Cancer, Hypoxia, and Metabolism(27), Mass Spectrometry Techniques and Applications(27)

Publications273 total

Erratum to “Establishing and characterizing the molecular profiles, cellular features, and clinical utility of a patient-derived xenograft model using benign prostatic tissues” (Lab Invest 2024 Oct;104(10):102129)
Laboratory Investigation·2026
Supplementary Figure S1 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Figure S4 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Figure S2 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Figure S5 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Data from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Table 1 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Supplementary Figure S3 from Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
2025Open Access
Identification of serum protein biomarkers for clear cell renal cell carcinoma using patient-derived xenografts
Journal of Clinical Investigation·2025Open Access
CRISPR screen reveal that FXYD5 is a potential ligand for Siglec-7 9337
The Journal of Immunology·2025Open Access
Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer
Cell Reports Medicine·2025Open Access
A microneedle device for rapid dermal interstitial fluid sampling
Science Advances·2025· 2 citedOpen Access
FTO inhibition attenuates renal fibrosis by downregulating ferroptosis activator ACSL4 and profibrotic factor TGFBI
iScience·2025· 1 citedOpen Access
Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis
Cancer Research·2025· 1 cited
Novel Aza-podophyllotoxin Derivative Inhibits Growth of Triple-Negative Breast Cancer
ACS Omega·2025Open Access
Integrated Plasma and Tumor Proteomics of Nasopharyngeal Carcinoma in a Moroccan Cohort
International Journal of Molecular Sciences·2025Open Access
Abstract 6879: Inhibition of triple-negative breast cancer progression via ribosomal protein(s) modulation
Cancer Research·2025
Abstract 7007: Identifying novel non-allosteric PIM1 degraders to overcome treatment resistance in triple negative breast cancer
Cancer Research·2025
Abstract 4325: FXYD5 plays diverse roles in immune evasion and tumor progression in prostate cancer
Cancer Research·2025· 1 cited
Abstract 4292: Targeting YB-1 as a treatment strategy for high-grade serous ovarian carcinoma
Cancer Research·2025
page 1 of 14Next →

Frequent Co-authors

Samir Hanash(17), Abel Bermudez(12), Vítor M. Faça(10), Scott A. McLuckey(9), Paul A. Chrisman(8), Jason M. Hogan(7), Martin McIntosh(6), Fernando Jose Garcia-Marques(6), Carolyn R. Bertozzi(5), En‐Chi Hsu(5), Tanya Stoyanova(5), Hong Wang(5), Sanjiv S. Gambhir(4), Alexei L. Krasnoselsky(4), Qing Zhang(4), Alice Chin(4), Meghan A. Rice(4), Ross L. Prentice(4), Parag Mallick(3), Ramasamy Paulmurugan(3)